共 240 条
[1]
Kirchhof P(2016)2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS Eur J Cardiothorac Surg 50 e1-e88
[2]
Benussi S(2018)Mechanisms and treatments of oxidative stress in atrial fibrillation Curr Pharm Des 24 3062-3071
[3]
Kotecha D(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 e1-76
[4]
Ahlsson A(2021)2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 42 373-498
[5]
Atar D(2020)Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models Europace 22 748-760
[6]
Casadei B(2020)Relationship between plasma cancer antigen (CA)-125 level and one-year recurrence of atrial fibrillation after catheter ablation Clinica Chimica Acta 502 201-206
[7]
Castella M(2016)Association between baseline natriuretic peptides and atrial fibrillation recurrence after catheter ablation a meta-analysis Int Heart J 57 183-189
[8]
Diener HC(2013)Carbohydrate antigen 125: a new biomarker in heart failure Cardiol Rev 21 23-26
[9]
Heidbuchel H(2012)New mechanism of elevated CA125 in heart failure: the mechanical stress and inflammatory stimuli initiate CA125 synthesis Med Hypotheses 79 381-383
[10]
Hendriks J(2018)NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure Cytokine 111 13-19